IMPLEMENTING TREAT-TO-TARGET URATE-LOWERING THERAPY DURING HOSPITALISATIONS FOR GOUT FLARES: A PROSPECTIVE COHORT STUDY

被引:0
|
作者
Russell, Mark D. [1 ]
Ameyaw-Kyeremeh, Louise [2 ]
Dell'Accio, Flora [1 ]
Lapham, Heather [2 ]
Head, Natalie [2 ]
Stovin, Christopher [1 ]
Patel, Vishit [1 ]
Clarke, Benjamin [2 ]
Nagra, Deepak [1 ]
Alveyn, Edward [1 ]
Adas, Maryam A. [1 ]
Bechman, Katie [1 ]
de la Puente, Maria A. [3 ]
Ellis, Benjamin [4 ]
Byrne, Corrine [5 ]
Patel, Rina [5 ]
Rutherford, Andrew I. [2 ]
Cantle, Fleur [6 ]
Norton, Sam [1 ]
Roddy, Edward [7 ]
Hudson, Joanna [3 ]
Cope, Andrew P. [1 ]
Galloway, James B. [1 ]
机构
[1] Kings Coll London, Ctr Rheumat Dis, London, England
[2] Kings Coll Hosp NHS Fdn Trust, Dept Rheumatol, London, England
[3] Kings Coll London, Dept Psychol, London, England
[4] Imperial Coll Healthcare NHS Fdn Trust, Dept Rheumatol, London, England
[5] Kings Coll Hosp NHS Fdn Trust, Dept Pharm, London, England
[6] Kings Coll Hosp NHS Fdn Trust, Dept Emergency Med, London, England
[7] Keele Univ, Sch Med, Keele, Staffs, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P085
引用
收藏
页码:I65 / I66
页数:2
相关论文
共 50 条
  • [31] Prediction of renal and cardiometabolic outcomes in gout during urate-lowering therapy by sonography
    Calabuig, Irene
    Marty-Ane, Anne
    Norberciak, Laurene
    Budzik, Jean-Francois
    Legrand, Julie
    Martinez-Sanchis, Agustin
    Pascart, Tristan
    Andres, Mariano
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2450 - 2459
  • [32] Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy
    Becker, Michael A.
    MacDonald, Patricia A.
    Hunt, Barbara J.
    Lademacher, Christopher
    joseph-Ridge, Nancy
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2008, 27 (6-7): : 585 - 591
  • [33] Atrial Fibrillation Risk and Urate-Lowering Therapy in Patients with Gout: A Cohort Study Using a Clinical Database
    Liu, Ching-Han
    Huang, Shih-Chung
    Yin, Chun-Hao
    Huang, Wei-Chun
    Chen, Jin-Shuen
    Chen, Yao-Shen
    Gan, Su-Ting
    Tzou, Shiow-Jyu
    Hsu, Ching-Tsai
    Wu, Hao-Ming
    Wang, Wen-Hwa
    BIOMEDICINES, 2023, 11 (01)
  • [34] Quantitative assessment of crystal dissolution in gout during urate-lowering therapy with computer-aided MicroPure imaging: a cohort study
    Wang, Qiao
    Bao, Hui
    Guo, Le-Hang
    Jin, Feng-Shan
    Li, Xiao-Long
    Yin, Hao-Hao
    Yue, Wen -Wen
    Zhu, An-Qi
    Wang, Li -Fan
    Sun, Li -Ping
    Xu, Hui-Xiong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [35] Treat-to-target Urate-lowering Therapy Reduces Gout Flare Burden: Post-hoc Analysis of a Multicenter, Randomized, Double-blind, Non-inferiority Trial
    Qu, Joshua
    Helget, Lindsay
    Androsenko, Maria
    Wu, Hongsheng
    Kramer, Bridget
    Newcomb, Jefferey
    Brophy, Mary
    Davis-Karim, Anne
    England, Bryant
    Ferguson, Ryan
    Pillinger, Michael
    Neogi, Tuhina
    Palevsky, Paul
    O'Dell, James
    Mikuls, Ted R.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1630 - 1632
  • [36] FACTORS INFLUENCING THE FREQUENCY OF ARTHRITIS FLARES IN PATIENTS WITH GOUT NOT RECEIVING URATE-LOWERING THERAPY: RESULTS FROM A PILOT RETROSPECTIVE STUDY
    Eliseev, S.
    Zhelyabina, V.
    Kuzmina, I.
    Chikina, N.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S534 - S534
  • [37] Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study
    Ebstein, Esther
    Forien, Marine
    Norkuviene, Eleonora
    Richette, Pascal
    Mouterde, Gael
    Daien, Claire
    Ea, Hang-Korng
    Briere, Claire
    Liote, Frederic
    Petraitis, Mykolas
    Bardin, Thomas
    Ora, Jeremy
    Dieude, Philippe
    Ottaviani, Sebastien
    RHEUMATOLOGY, 2019, 58 (03) : 410 - 417
  • [38] Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout
    Tedeschi, Sara K.
    Hayashi, Keigo
    Zhang, Yuqing
    Choi, Hyon
    Solomon, Daniel H.
    ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [39] Urate Lowering Therapy in the Treatment of Gout: A Multicenter, Randomized, Double-blind Comparison of Allopurinol and Febuxostat Using a Treat-to-Target Strategy
    O'Dell, James
    Neogi, Tuhina
    Pillinger, Michael
    Palevsky, Paul
    Newcomb, Jeff
    Brophy, Mary
    Wu, Hongsheng
    Davis-Karim, Annie
    Ferguson, Ryan
    Pittman, David
    Terkeltaub, Robert
    Cannella, Amy
    England, Bryant
    Helget, Lindsay
    Mikuls, Ted
    Taylor, Tomas
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3968 - 3970
  • [40] TREATING TO TARGET ULTRASOUND FINDINGS ONLY IS EQUIVALENT TO URATE-LOWERING THERAPY IN PATIENTS WITH CHRONIC GOUT.
    Kume, K.
    Amano, K.
    Yamada, S.
    Kanazawa, T.
    Ohta, H.
    Hatta, K.
    Komori, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 982 - 983